MedicarePartD.guide

A non-government resource built from CMS public data

SGLT2 inhibitors on every 2026 Nevada Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Nevada cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
SGLT2 inhibitors by 2026 Nevada Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-112Wellcare Classic$2.70/moS4802-093Wellcare Value Script$2.70/moS4802-161Humana Value Rx Plan$43.70/moS5884-208HealthSpring Extra Rx$52.60/moS5617-379AARP Medicare Rx Saver from UHC$76.70/moS5921-373HealthSpring Assurance Rx$95.60/moS5617-143SilverScript Choice$97.40/moS5601-058AARP Medicare Rx Preferred from UHC$139.10/moS5921-410Humana Premier Rx Plan$148.70/moS5884-175
JardianceempagliflozinTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 318%QL 30/30dTier 317%QL 30/30dTier 319%QL 30/30dTier 320%QL 30/30dTier 318%QL 30/30dTier 318%QL 30/30dTier 3$45.00QL 30/30d
FarxigadapagliflozinTier 325%QL 30/30dNot coveredNot coveredTier 318%QL 30/30dTier 317%QL 30/30dNot coveredTier 320%QL 30/30dTier 318%QL 30/30dNot coveredTier 3$45.00QL 30/30d
dapagliflozingeneric FarxigaTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 318%QL 30/30dTier 317%QL 30/30dTier 319%QL 30/30dTier 320%QL 30/30dTier 318%QL 30/30dTier 318%QL 30/30dTier 3$45.00QL 30/30d
InvokanacanagliflozinNot coveredTier 431%QL 60/30dTier 440%QL 60/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
SteglatroertugliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
InpefasotagliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.